Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA21004 vs venlafaxine XR in Asian patients with MDD
CTR20132059Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), sponsored by Lundbeck. Started Mar 2014; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20132059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132059.